Logo

Homer Pearce

Aug 09, 2007
Premium
Kylin Therapeutics this week said it has appointed Homer Pearce to its board of directors.
 
Pearce was previously vice president of cancer research and clinical investigation at Eli Lilly. He holds a PhD in chemistry from Harvard University.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.